ArticleCancer reports (Hoboken, N.J.)2022

Identification of PSMD14 as a potential novel prognosis biomarker and therapeutic target for osteosarcoma.

Yubao Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.